Azacitidine-induced remission enables allogeneic transplantation in <i>TET2</i>/<i>BCOR</i>-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report
Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report
Jérôme Tamburini, Gregory Mathoux, David M. Weinstock, Stavroula Masouridi et al.
Journal
Haematologica
Topics
Acute Myeloid Leukemia Research
article
Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report
Jérôme Tamburini, Gregory Mathoux, David M. Weinstock, Stavroula Masouridi, André R. Durham, Kristóf Égervári, Hana Abouzeid, David Sibon, Thomas A. Mckee, Chiara De Bernardi, Carmen de Ramon Ortiz, Olivier Hermine
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Délégation Paris 5 (FR), Inserm (FR), Université Paris-Est Créteil (FR), Université Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), University Hospital of Geneva (CH), Dana-Farber Cancer Institute (US), Institut des Maladies Génétiques Imagine (FR), Geneva College (US)